CelLBxHealth PLC expects to generate £3-4 million in revenue in 2027, more than doubling its anticipated 2026 turnover of £1.8 million. The cancer diagnostics firm saw its Q3 new business triple to £300,000 year-on-year and secured additional contracts, including a radiopharmaceutical clinical study and a US pharma sample processing deal. Cost reductions have cut cash operating losses by 60% to £4 million in nine months, creating a leaner business with a stronger commercial pipeline. The company holds £1.4 million in cash and expects an £800,000 R&D tax credit soon, extending its funding runway into early 2027 despite increased Q4 spending.
CelLBxHealth's commercial pipeline progress is the subject here, with Pluang's Health sector data providing market context. As of Oct 21, 2026 12:11 WIB, 133 of 150 priced Health-sector US stocks rose while 17 fell. Notable movers include TDOC at USD 6.19 with a +8.03% change, RVMD at USD 196.55 with +7.91%, and AMWL at USD 13.25 with +7.46%.
A webinar titled "Ready for AI?" scheduled for October 29, 2026, will discuss how artificial intelligence is reshaping public relations by changing how information is found, evaluated, and shared. Experts will share insights on maintaining message vi...
17a-4 LLC introduced DataParser Hub, an API that enables clients to integrate proprietary messaging and collaboration data into Microsoft 365 Purview and Copilot. This solution supports over 30 data types from platforms like Slack, Zoom, and Webex, a...
IBA has treated the first patient in the C-FLASH-01 clinical trial, the first human study testing ConformalFLASH® proton therapy. This trial, conducted at Penn Medicine with FDA approval, explores the feasibility of using ultra-high dose rate proton ...
IBA has treated the first patient in the C-FLASH-01 clinical trial, testing its ConformalFLASH® proton therapy for head and neck cancer re-irradiation. This trial, led by Penn Medicine and approved by the FDA, explores ultra-high dose rate proton the...
WISeQey Corp. completed its redomiciliation and began trading on Nasdaq and the SIX Swiss Exchange, marking a new phase focused on integrating its quantum cybersecurity, digital identity, and space IoT technologies. Its subsidiary WISeSat.Space also ...
